Cargando…

The Experience of a Tertiary Reference Hospital in the Study of Rare Neurological Diseases

Background and Objectives: Rare diseases (RDs) are life-threatening or chronically impairing conditions that affect about 6% of the world’s population. RDs are often called ‘orphan’ diseases, since people suffering from them attract little support from national health systems. Aim: The aim of this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sintila, Styliani-Aggeliki, Boziki, Marina, Bakirtzis, Christos, Stardeli, Thomai, Smyrni, Nikoletta, Nikolaidis, Ioannis, Parissis, Dimitrios, Afrantou, Theodora, Karapanayiotides, Theodore, Koutroulou, Ioanna, Giantzi, Virginia, Theotokis, Paschalis, Kesidou, Evangelia, Xiromerisiou, Georgia, Dardiotis, Efthimios, Ioannidis, Panagiotis, Grigoriadis, Nikolaos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959728/ https://www.ncbi.nlm.nih.gov/pubmed/36837468 http://dx.doi.org/10.3390/medicina59020266

Ejemplares similares

Long-Term Efficacy Outcomes of Natalizumab vs. Fingolimod in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis: Real-World Data From a Multiple Sclerosis Reference Center
por: Boziki, Marina, et al.
Publicado: (2021)

Secondary Central Nervous System Demyelinating Disorders in the Elderly: A Narrative Review
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Blood Metabolomics May Discriminate a Sub-Group of Patients with First Demyelinating Episode in the Context of RRMS with Increased Disability and MRI Characteristics Indicative of Poor Prognosis
por: Boziki, Marina, et al.
Publicado: (2022)

Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response
por: Boziki, Marina, et al.
Publicado: (2022)

CNS Ageing in Health and Neurodegenerative Disorders
por: Kesidou, Evangelia, et al.
Publicado: (2023)

The Role of Diet and Interventions on Multiple Sclerosis: A Review
por: Stoiloudis, Panagiotis, et al.
Publicado: (2022)

Estimating Everyday Neuropsychological Functioning in Multiple Sclerosis: Reliability and Validity of the Greek Multiple Sclerosis Neuropsychological Questionnaire
por: Konstantinopoulou, Eleni, et al.
Publicado: (2018)

Biomarkers in Rare Demyelinating Disease of the Central Nervous System
por: Boziki, Marina, et al.
Publicado: (2020)

The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics
por: Barmpagiannos, Konstantinos, et al.
Publicado: (2023)

Lumbar spine intrathecal transplantation of neural precursor cells promotes oligodendrocyte proliferation in hot spots of chronic demyelination
por: Theotokis, Paschalis, et al.
Publicado: (2021)

COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction
por: Boziki, Marina, et al.
Publicado: (2023)

A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination
por: Boziki, Marina, et al.
Publicado: (2021)

Developmental Cues and Molecular Drivers in Myelinogenesis: Revisiting Early Life to Re-Evaluate the Integrity of CNS Myelin
por: Dermitzakis, Iasonas, et al.
Publicado: (2022)

Spatio-temporal expression profile of NGF and the two-receptor system, TrkA and p75NTR, in experimental autoimmune encephalomyelitis
por: Delivanoglou, Nickoleta, et al.
Publicado: (2020)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Humoral response in experimental autoimmune encephalomyelitis targets neural precursor cells in the central nervous system of naive rodents
por: Kesidou, Evangelia, et al.
Publicado: (2017)

The Administrative Prevalence of Multiple Sclerosis in Greece on the Basis of a Nationwide Prescription Database
por: Bakirtzis, Christos, et al.
Publicado: (2020)

A Greek Validation Study of the Multiple Sclerosis Work Difficulties Questionnaire-23
por: Bakirtzis, Christos, et al.
Publicado: (2021)

Origin and Emergence of Microglia in the CNS—An Interesting (Hi)story of an Eccentric Cell
por: Dermitzakis, Iasonas, et al.
Publicado: (2023)

Prevention, Intervention and Care of Neurodegenerative Diseases
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination
por: Theotokis, Paschalis, et al.
Publicado: (2016)

Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review
por: Koutroulou, Ioanna, et al.
Publicado: (2020)

Prevalence of patent foramen ovale in the Greek population is high and impacts on the interpretation of the risk of paradoxical embolism (RoPE) score
por: Koutroulou, Ioanna, et al.
Publicado: (2020)

N-Acetylcysteine Administration Attenuates Sensorimotor Impairments Following Neonatal Hypoxic-Ischemic Brain Injury in Rats
por: Kesidou, Evangelia, et al.
Publicado: (2022)

Application of antibody phage display to identify potential antigenic neural precursor cell proteins
por: Paspaltsis, Ioannis, et al.
Publicado: (2020)

Off-label intravenous thrombolysis for early recurrent brain embolism associated with aortic arch thrombus
por: Koutroulou, Ioanna, et al.
Publicado: (2021)

Optical Coherence Tomography and Optical Coherence Tomography with Angiography in Multiple Sclerosis
por: Chalkias, Ioannis-Nikolaos, et al.
Publicado: (2022)

Anti-MOG Positive Bilateral Optic Neuritis and Brainstem Encephalitis Secondary to COVID-19 Infection: A Case Report
por: Tsouris, Zisis, et al.
Publicado: (2022)

Peripheral Inflammatory Markers TNF-α and CCL2 Revisited: Association with Parkinson’s Disease Severity
por: Xiromerisiou, Georgia, et al.
Publicado: (2022)

Smell as a Disease Marker in Multiple Sclerosis
por: Printza, Athanasia, et al.
Publicado: (2022)

Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options
por: Andravizou, Athina, et al.
Publicado: (2019)

Novel contributors to B cell activation during inflammatory CNS demyelination; An oNGOing process
por: Damianidou, Olympia, et al.
Publicado: (2022)

RNA Editing Alterations Define Disease Manifestations in the Progression of Experimental Autoimmune Encephalomyelitis (EAE)
por: Dafou, Dimitra, et al.
Publicado: (2022)

Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
por: Marogianni, Chrysoula, et al.
Publicado: (2020)

EEG-Neurofeedback as a Potential Therapeutic Approach for Cognitive Deficits in Patients with Dementia, Multiple Sclerosis, Stroke and Traumatic Brain Injury
por: Vilou, Irini, et al.
Publicado: (2023)

Multiple Sclerosis: Shall We Target CD33?
por: Siokas, Vasileios, et al.
Publicado: (2020)

EEG Window Length Evaluation for the Detection of Alzheimer’s Disease over Different Brain Regions
por: Tzimourta, Katerina D., et al.
Publicado: (2019)

Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
por: Kim, Min Joung, et al.
Publicado: (2018)

How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?
por: Rashidbenam, Zahra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dtupvfu7ar2i7uk256onlt7er4